News | June 26, 2013

Zoetis Animal Health Selects Global Vision For Worldwide Deployment Of Automated Proofreading Solutions

Source: GlobalVision

Zoetis Animal Health purchases Docu-Proof, Digital-Page, ScanTVS and BarProof worldwide

Montreal, Canada - Global Vision, today announced that it has been selected by Zoetis Animal Health, for worldwide deployment of its automated proofreading solutions, extending the company’s long-standing strategic partnership with the former animal health business unit of Pfizer Inc.

Zoetis Animal Health selected Global Vision’s best-in-class technologies for checking text, artwork, print and barcodes. This implementation will provide end-to-end inspection, enabling Zoetis Animal Health  to secure their entire brand packaging workflow:   

  • Docu-Proof - text verification and comparison for Regulatory Affairs
  • Digital-Page - artwork & proof revision comparator
  • ScanTVS - print inspection system
  • BarProof - barcode decoder & verification

“All of our automated proofreading solutions are designed with one vision in mind and that is to: Reduce Risk to Brand Packaging,” explained Reuben Malz, President of Global Vision. “As we service Zoetis Animal Health or any one of the largest pharmaceutical companies in the world we are always striving to maintain this vision.”

About Global Vision

Global Vision is the world leader in the design and delivery of automated proofreading solutions. Its complete suite of advanced solutions featuring text-based, pixel-based and Braille inspection technologies are designed to eliminate printed artwork, text verification, and text comparison related errors, providing end-to-end security at every stage of the workflow process.

Global Vision solutions are widely interoperable and have received commercial endorsement from the world’s leading Pharmaceutical, Consumer Packaged Goods (CPG), and Artwork Management companies. 

Headquartered in Montreal, Canada, Global Vision has worldwide representation. For more information, please visit www.GlobalVisionInc.com.

Source: GlobalVision